Mapatumumab (Anti-TNFRSF10A / TRAILR1 / CD261)
Mapatumumab (Anti-TNFRSF10A / TRAILR1 / CD261) is a fully human IgG1 agonistic monoclonal antibody that targets tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) with apoptosis promoting and potential antitumor activities. MW : 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2332 |
Sku # | A2332-1mg*5 |
Pricing | 1mg*5, $1690.00 |